Raju Prasad

CIK: 0001968317

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (38.7%)

Position reduction

Option Exercises (M)8 (25.8%)

Derivative conversions

Awards (A)9 (29.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (6.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRSP

CRISPR Therapeutics AG

Officer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

CRSP
CRISPR Therapeutics AG
Aug 7, 2026
Gift(G)
Direct
750 shares-
CRSP
CRISPR Therapeutics AG
May 29, 2026
Award(A)
Restricted Stock Units
Direct
19.5K shares-
CRSP
CRISPR Therapeutics AG
Mar 23, 2026
Sale(S)
Direct
3.7K shares at avg. $46.78$173K
CRSP
CRISPR Therapeutics AG
Mar 20, 2026
Award(A)
Stock Option (Right to Buy)
Direct
38.5K shares-
CRSP
CRISPR Therapeutics AG
Mar 20, 2026
Award(A)
Restricted Stock Units
Direct
27.5K shares-
CRSP
CRISPR Therapeutics AG
Mar 20, 2026
Exercise(M)
Direct
6.3K shares-
CRSP
CRISPR Therapeutics AG
Mar 16, 2026
Sale(S)
Direct
5.8K shares at avg. $48.26$282K
CRSP
CRISPR Therapeutics AG
Mar 16, 2026
Sale(S)
Direct
4K shares at avg. $48.26$194K
CRSP
CRISPR Therapeutics AG
Mar 16, 2026
Gift(G)
Direct
750 shares-
CRSP
CRISPR Therapeutics AG
Mar 14, 2026
Exercise(M)
Direct
10K shares-
CRSP
CRISPR Therapeutics AG
Mar 14, 2026
Exercise(M)
Direct
6.9K shares-
CRSP
CRISPR Therapeutics AG
Jan 22, 2026
Exercise(M)
Direct
35K shares at avg. $45.15$1.6M
CRSP
CRISPR Therapeutics AG
Jan 22, 2026
Sale(S)
Direct
35K shares at avg. $60.19$2.1M
CRSP
CRISPR Therapeutics AG
Jan 6, 2026
Exercise(M)
Direct
23.4K shares at avg. $45.15$1.1M
CRSP
CRISPR Therapeutics AG
Jan 6, 2026
Exercise(M)
Direct
6.3K shares at avg. $44.31$281K
CRSP
CRISPR Therapeutics AG
Jan 6, 2026
Sale(S)
Direct
18.9K shares at avg. $60.18$1.1M
CRSP
CRISPR Therapeutics AG
Jan 6, 2026
Sale(S)
Direct
5K shares at avg. $60.00$300K
CRSP
CRISPR Therapeutics AG
Jan 6, 2026
Sale(S)
Direct
5.8K shares at avg. $60.21$347K
CRSP
CRISPR Therapeutics AG
Dec 22, 2025
Sale(S)
Direct
3.5K shares at avg. $55.10$194K
CRSP
CRISPR Therapeutics AG
Dec 22, 2025
Sale(S)
Direct
5.5K shares at avg. $56.33$308K
CRSP
CRISPR Therapeutics AG
Dec 22, 2025
Sale(S)
Direct
1K shares at avg. $56.89$57K
CRSP
CRISPR Therapeutics AG
Oct 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
16.5K shares-
CRSP
CRISPR Therapeutics AG
May 30, 2025
Award(A)
Restricted Stock Units
Direct
20K shares-
CRSP
CRISPR Therapeutics AG
Mar 21, 2025
Sale(S)
Direct
2.2K shares at avg. $41.23$91K
CRSP
CRISPR Therapeutics AG
Mar 20, 2025
Exercise(M)
Direct
6.3K shares-

		Type	Shares	Price		Ownership
Aug 7, 2026	CRSP CRISPR Therapeutics AG	Gift(G)	750	-	$0	Direct
May 29, 2026	CRSP CRISPR Therapeutics AG	Award(A) Restricted Stock Units	19,500	-	-	Direct
Mar 23, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	3,708	$46.78	$173,460	Direct
Mar 20, 2026	CRSP CRISPR Therapeutics AG	Award(A) Stock Option (Right to Buy)	38,499	-	-	Direct
Mar 20, 2026	CRSP CRISPR Therapeutics AG	Award(A) Restricted Stock Units	27,500	-	-	Direct
Mar 20, 2026	CRSP CRISPR Therapeutics AG	Exercise(M)	6,250	-	$0	Direct
Mar 16, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	5,848	$48.26	$282,224	Direct
Mar 16, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	4,021	$48.26	$194,053	Direct
Mar 16, 2026	CRSP CRISPR Therapeutics AG	Gift(G)	750	-	$0	Direct
Mar 14, 2026	CRSP CRISPR Therapeutics AG	Exercise(M)	10,000	-	$0	Direct
Mar 14, 2026	CRSP CRISPR Therapeutics AG	Exercise(M)	6,875	-	$0	Direct
Jan 22, 2026	CRSP CRISPR Therapeutics AG	Exercise(M)	34,972	$45.15	$1,578,986	Direct
Jan 22, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	34,972	$60.19	$2,104,965	Direct
Jan 6, 2026	CRSP CRISPR Therapeutics AG	Exercise(M)	23,361	$45.15	$1,054,749	Direct
Jan 6, 2026	CRSP CRISPR Therapeutics AG	Exercise(M)	6,339	$44.31	$280,881	Direct
Jan 6, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	18,933	$60.18	$1,139,386	Direct
Jan 6, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	5,004	$60.00	$300,240	Direct
Jan 6, 2026	CRSP CRISPR Therapeutics AG	Sale(S)	5,763	$60.21	$347,010	Direct
Dec 22, 2025	CRSP CRISPR Therapeutics AG	Sale(S)	3,528	$55.10	$194,401	Direct
Dec 22, 2025	CRSP CRISPR Therapeutics AG	Sale(S)	5,472	$56.33	$308,262	Direct
Dec 22, 2025	CRSP CRISPR Therapeutics AG	Sale(S)	1,000	$56.89	$56,886	Direct
Oct 3, 2025	CRSP CRISPR Therapeutics AG	Award(A) Stock Option (Right to Buy)	16,500	-	-	Direct
May 30, 2025	CRSP CRISPR Therapeutics AG	Award(A) Restricted Stock Units	20,000	-	-	Direct
Mar 21, 2025	CRSP CRISPR Therapeutics AG	Sale(S)	2,197	$41.23	$90,582	Direct
Mar 20, 2025	CRSP CRISPR Therapeutics AG	Exercise(M)	6,250	-	-	Direct

1-25 of 31 transactions

About Prasad Raju

Prasad Raju (SEC CIK 0001968317) files insider reports with the SEC as Chief Financial Officer of CRISPR Therapeutics AG (CRSP).

Signal8 holds 12 ownership filings by Prasad Raju, all Form 4s, filed between Oct 18, 2024 and Aug 11, 2026. Those filings report 31 transactions, from Oct 16, 2024 to Aug 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Prasad Raju's filings is in BOSTON, MA.

Recent filings by Prasad Raju

Aug 7, 2026: Gift of CRSP shares (Form 4, code G).
May 29, 2026: Grant or award of CRSP derivative securities (Form 4, code A).
Mar 23, 2026: Open-market sale of CRSP shares (Form 4, code S).
Mar 20, 2026: Grants or awards of CRSP derivative securities (2 lines, Form 4, code A).
Mar 20, 2026: Option exercise of CRSP shares (Form 4, code M).

Other insiders filing for CRISPR Therapeutics AG (CRSP)

Sakhamuri Sivakesava, Chief Technical Officer
Silver Andrew Jacob, Chief Financial Officer
KASINGER JAMES R., General Counsel and Secretary
Kulkarni Samarth, Chief Executive Officer
Patel Naimish, Chief Medical Officer
George Simeon, Director

How to read Form 4 transaction codes